Patents by Inventor Adam Cook

Adam Cook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11488693
    Abstract: Among other things, unstructured text items are processed to identify elements of the unstructured text items relevant to classification rules of quality metrics applicable to services provided by a healthcare provider with respect to diseases, conditions, or interventions of patients. The classification rules define classifications of patients based on diseases, conditions, or interventions of patients or on aspects of the services provided. Through a user interface, the unstructured text items, the identified elements, and user interface controls for classifying the patients with respect to the classification rules, based on the identified elements, are presented to the user.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: November 1, 2022
    Assignee: UPMC
    Inventors: Melissa Castine, Girish Chavan, Carly Cook, Rebecca Jacobson, Jody Madala, Amy Malanga, Eugene Tseytlin, Adam Yee
  • Publication number: 20220313676
    Abstract: Provided herein are compounds of the Formula I: or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X1, X2, X3, X4, Ring D, E, Ra, Rb, n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
    Type: Application
    Filed: December 1, 2020
    Publication date: October 6, 2022
    Inventors: Steven W. ANDREWS, Sean ARONOW, James F. BLAKE, Barbara J. BRANDHUBER, James COLLIER, Adam COOK, Julia HAAS, Yutong JIANG, Gabrielle R. KOLAKOWSKI, Elizabeth A. MCFADDIN, Megan L. MCKENNEY, Oren T. MCNULTY, Andrew T. METCALF, David A. MORENO, Ginelle A. RAMANN, Tony P. TANG, Li REN, Shane M. WALLS
  • Publication number: 20220293135
    Abstract: Disclosed herein are computer-implemented method, system, and computer-readable storage-medium embodiments for implementing user-generated templates for segmented multimedia performances. An embodiment includes at least one computer processor configured to transmit a first version of a content instance and corresponding metadata. The first version of the content instance may include a plurality of structural elements, with at least one structural element corresponding to at least part of the metadata. The first content instance may be transformed by a rendering engine triggered by the at least one computer processor.
    Type: Application
    Filed: April 4, 2022
    Publication date: September 15, 2022
    Inventors: Jeffrey Christopher SMITH, Perry Raymond Cook, David Adam Steinwedel
  • Publication number: 20220290140
    Abstract: Featured are trans-cyclooctene and tetrazine compounds. Also provided are methods for evaluating the biodistribution and/or concentration of a biomolecule in a subject.
    Type: Application
    Filed: August 19, 2020
    Publication date: September 15, 2022
    Inventors: Brendon Ellery COOK, Maciej Adam KALISZCZAK, Laurent MARTARELLO, Nathan Edward GENUNG, Sivaraman DANDAPANI, Eric Edward SWAYZE, William John DRURY, III, Chrissa Ann DWYER
  • Patent number: 11247990
    Abstract: Provided herein are compounds of the Formula (I): and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein Ring A, X1, X2, X3, R1, R2 and R3 are as defined herein, which are inhibitors of one or more TAM kinases and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: February 15, 2022
    Assignee: ARRAY BIOPHARMA INC
    Inventors: Shelley Allen, Mark Laurence Boys, Adam Cook, John Gaudino, Ronald Jay Hinklin, Ellen Laird, Oren T. McNulty, Andrew T. Metcalf, Brad Newhouse, John E. Robinson
  • Publication number: 20210380609
    Abstract: In some embodiments, provided herein is a process for preparing a compound of Formula I or a pharmaceutically acceptable salt thereof, as disclosed herein.
    Type: Application
    Filed: August 13, 2021
    Publication date: December 9, 2021
    Inventors: Charles Todd EARY, Stacey SPENCER, Zack CRANE, Katelyn CHANDO, Sylvie ASSELIN, Weidong LIU, Mike WELCH, Adam COOK, Gabrielle R. KOLAKOWSKI, Andrew T. METCALF, David A. MORENO, Tony P. TANG
  • Patent number: 11149108
    Abstract: The present invention relates to formulations including a self-assembly monomer. In particular embodiments, the self-assembly monomer provides a thermoset having beneficial viscoelastic properties for printing methodologies. Methods of making and using such formulations are also provided.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: October 19, 2021
    Assignee: National Technology & Engineering Solutions of Sandia, LLC
    Inventors: Kylie Manning, Mathias C. Celina, Adam Cook
  • Patent number: 11104676
    Abstract: Provided herein are compounds of the Formula I: and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R1, R2, R9, X1 and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: August 31, 2021
    Assignee: Array BioPharma Inc.
    Inventors: Ronald Jay Hinklin, Shelley Allen, Patrick Barbour, Adam Cook, Joshua Dahlke, John Gaudino, Ellen Laird, Oren T. McNulty, Qian Zhao
  • Patent number: 11098064
    Abstract: In some embodiments, provided herein is a process for preparing a compound of Formula I or a pharmaceutically acceptable salt thereof, as disclosed herein.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: August 24, 2021
    Assignees: Loxo Oncology, Inc., Array BioPharma, Inc.
    Inventors: Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie Asselin, Weidong Liu, Mike Welch, Adam Cook, Gabrielle R. Kolakowski, Andrew T. Metcalf, David A. Moreno, Tony P. Tang
  • Publication number: 20210186959
    Abstract: Provided herein are compounds of the Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which A, B, X1, X2, X3, X4, Ring D, and E have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
    Type: Application
    Filed: February 2, 2021
    Publication date: June 24, 2021
    Inventors: Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, Elizabeth A. McFaddin, Megan L. McKenney, Oren T. McNulty, Andrew T. Metcalf, David A. Moreno, Tony P. Tang, Li Ren
  • Patent number: 10953005
    Abstract: Provided herein are compounds of the Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which A, B, X1, X2, X3, X4, Ring D, and E have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: March 23, 2021
    Assignee: Array Biopharma Inc.
    Inventors: Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, Elizabeth A. McFaddin, Megan L. McKenney, Oren T. McNulty, Andrew T. Metcalf, David A. Moreno, Tony P. Tang, Li Ren
  • Patent number: 10881652
    Abstract: Provided herein are compounds of the Formula I: or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X1, X2, X3, X4, Ring D, E, Ra, Rb, n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: January 5, 2021
    Assignee: Array Biopharma Inc.
    Inventors: Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier, Adam Cook, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, Elizabeth A. McFaddin, Megan L. McKenney, Oren T. McNulty, Andrew T. Metcalf, David A. Moreno, Ginelle A. Ramann, Tony P. Tang, Li Ren, Shane M. Walls
  • Publication number: 20200383966
    Abstract: Provided herein are compounds of the Formula I: or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X1, X2, X3, X4, Ring D, E, Ra, Rb, n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
    Type: Application
    Filed: September 23, 2019
    Publication date: December 10, 2020
    Inventors: Steven W. ANDREWS, Sean ARONOW, James F. BLAKE, Barbara J. BRANDHUBER, James COLLIER, Adam COOK, Julia HAAS, Yutong JIANG, Gabrielle R. KOLAKOWSKI, Elizabeth A. McFADDIN, Megan L. McKENNEY, Oren T. McNULTY, Andrew T. METCALF, David A. MORENO, Ginelle A. RAMANN, Tony P. TANG, Li REN, Shane M. WALLS
  • Publication number: 20200366681
    Abstract: Systems, methods, and computer-readable storage media for authenticating a user account with a synchronized content management system are disclosed. A synchronized online content management system may receive a request from a client device to access content in the content management system via a web browser that is running on the client device. The system may identify that a client-side application for the content management system has been installed on the client device and that the client-side application is already logged into a user account with the content management system. The system can cause the web browser to open a local host connection to the client-side application such that the web browser may be able to obtain from the client application some user account identifying information for the user account. The system can then cause the web browser to log into the user account by using the user account identifying information.
    Type: Application
    Filed: August 6, 2020
    Publication date: November 19, 2020
    Inventors: Josh Kaplan, Adam Cook, Stephen Poletto, Thomas Wright, Luke Faraone
  • Patent number: 10826050
    Abstract: The present invention relates, in part, to methods of preparing a safety battery. Methods can include dispensing a safety ink formulation between the two poles of a battery. Upon exposure to moisture, the formulation provides an electrical connection between two poles, thus minimizing electrical discharge and/or reducing the formation of electrochemically generated ions at the pole(s).
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: November 3, 2020
    Assignees: National Technology & Engineering Solutions of Sandia, LLC, Duracell U.S. Operations, Inc.
    Inventors: Bryan James Kaehr, Walter F. Paxton, Adam Cook, William Reinholtz, Michael Pozin
  • Publication number: 20200308194
    Abstract: In some embodiments, provided herein is a process for preparing a compound of Formula I or a pharmaceutically acceptable salt thereof, as disclosed herein.
    Type: Application
    Filed: June 16, 2020
    Publication date: October 1, 2020
    Inventors: Charles Todd EARY, Stacey SPENCER, Zack CRANE, Katelyn CHANDO, Sylvie ASSELIN, Weidong LIU, Mike WELCH, Adam COOK, Gabrielle R. KOLAKOWSKI, Andrew T. METCALF, David A. MORENO, Tony P. TANG
  • Patent number: 10766881
    Abstract: Provided herein are compounds of the general Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which X, R1, R2, R3, Ring A and z have the meanings given in the specification, which are inhibitors of FGFR1, FGFR2, FGFR3 and/or FGFR4 and are useful in the treatment and prevention of diseases which can be treated with an FGFR inhibitor, including diseases or disorders mediated by FGFR1, FGFR2, FGFR3 and/or FGFR4.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: September 8, 2020
    Assignee: Array Biopharma Inc.
    Inventors: Steven W. Andrews, James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt, Andrew T. Metcalf, David Moreno, Li Ren, Tony P. Tang
  • Patent number: 10757107
    Abstract: Systems, methods, and computer-readable storage media for authenticating a user account with a synchronized content management system are disclosed. A synchronized online content management system may receive a request from a client device to access content in the content management system via a web browser that is running on the client device. The system may identify that a client-side application for the content management system has been installed on the client device and that the client-side application is already logged into a user account with the content management system. The system can cause the web browser to open a local host connection to the client-side application such that the web browser may be able to obtain from the client application some user account identifying information for the user account. The system can then cause the web browser to log into the user account by using the user account identifying information.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: August 25, 2020
    Assignee: Dropbox, Inc.
    Inventors: Josh Kaplan, Adam Cook, Stephen Poletto, Thomas Wright, Luke Faraone
  • Patent number: 10745419
    Abstract: In some embodiments, provided herein is a process for preparing a compound of Formula I or a pharmaceutically acceptable salt thereof, as disclosed herein.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: August 18, 2020
    Assignees: Loxo Oncology Inc., Array Biopharma Inc.
    Inventors: Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie Asselin, Weidong Liu, Mike Welch, Adam Cook, Gabrielle R. Kolakowski, Andrew T. Metcalf, David A. Moreno, Tony P. Tang
  • Publication number: 20200216416
    Abstract: Provided herein are compounds of the Formula I: or pharmaceutically acceptable salts thereof, wherein X1, X2, X3, R1, R2, R3, R4, R5, R6 and R7 are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 9, 2020
    Applicant: Array BioPharma Inc.
    Inventors: Adam Cook, Ronald Jay Hinklin, Oren T. McNulty